Transition Therapeutics Acquires All Remaining Shares of NeuroMedix Inc.


Transition Therapeutics Inc. announced that Transition has acquired all of the remaining outstanding common shares of NeuroMedix Inc. pursuant to the compulsory acquisition provisions of the Business Corporations Act (Ontario). Transition now beneficially owns 100% of the common shares of NeuroMedix.

NeuroMedix's common shares were delisted from the Toronto Venture Stock Exchange as of the close of the market on May 15, 2007. NeuroMedix has applied to securities regulators to cease to be a reporting issuer under Canadian securities laws.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances